Concert Pharmaceuticals Inc (CNCE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

65 HAYDEN AVENUE LEXINGTON, MA 02421

Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company. The company focuses on the use of deuterium to enhance the effects of approved drugs. Concert Pharmaceuticals offers its products throughout the United States.

Data based on most recent fiscal year report
Market Cap471.111 Million Shares Outstanding22.77 Million Avg Volume462.985 Thousand
1-Yr BETA vs S&P TR1.596 Current Ratio31.9 Quick Ratio31.9
View SEC Filings from CNCE instead.
Q1 2019 All Institutions Hedge Funds 1
To trade CNCE now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 92 20 (2.04%)
Aggregate 13F shares on 03/31/2019: 17.747 Million 7.948 Million
Aggregate 13F shares on 12/31/2018: 17.735 Million 7.22 Million
Percent change: 0.07% 10.09%
Funds creating new positions: 12 5
Funds Adding to an existing position: 34 8
Funds closing out their position: 13 1
Funds reducing their position: 31 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CNCE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

386.3 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

14.6 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALDRICH RICHARD

  • Director
0 2019-06-13 2

AUCHINCLOSS THOMAS G

  • Director
0 2019-06-13 3

BARRETT RONALD W

  • Director
0 2019-06-13 1

JAEGER WILFRED E

  • Director
0 2019-06-13 1

HUTT PETER BARTON

  • Director
0 2019-06-13 1

VAN HEEK CHRISTI

  • Director
0 2019-06-13 1

HOEILAND JESPER

  • Director
0 2019-06-13 2

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
169,589 2019-06-10 2

WIERENGA WENDALL

  • Director
0 2019-05-15 0

FITZGERALD MEGHAN

  • Director
18,729 2019-05-03 0

TUNG ROGER D CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
779,056 2019-04-23 4

CASSELLA JAMES V CHIEF DEVELOPMENT OFFICER

  • Officer
21,165 2019-03-31 2

STUART NANCY CHIEF OPERATING OFFICER

  • Officer
98,843 2019-03-31 5

LYNCH RYAN PAO

  • Officer
3,996 2019-03-31 2

HERSCHA LYNETTE SEE REMARK

  • Officer
0 2019-02-19 0

BECKER MARC A. CFO, PFO

  • Officer
0 2019-01-04 1

BECKER MARC

  • Director
0 2018-06-25 0

SILVERMAN ROBERT SENIOR VP, GENERAL COUNSEL

  • Officer
50,307 2017-03-09 0

DAWS D. RYAN CHIEF FINANCIAL OFFICER

  • Officer
0 2017-01-04 0

MCGOWAN PAULINE VP, FINANCE

  • Officer
0 2016-01-07 0

JAEGER WILFRED E

THREE ARCH MANAGEMENT III LLC

THREE ARCH MANAGEMENT IV, L.L.C.

  • Director
75,292 2015-12-14 0

SCHUHSLER HELMUT

  • Director
0 2015-06-11 0

THREE ARCH MANAGEMENT IV, L.L.C.

JAEGER WILFRED E

WAN MARK A

THREE ARCH PARTNERS IV LP

THREE ARCH ASSOCIATES IV LP

  • Director
  • 10% Owner
569,427 2014-11-18 0

THREE ARCH MANAGEMENT III LLC

THREE ARCH PARTNERS III LP

THREE ARCH ASSOCIATES III LP

WAN MARK A

JAEGER WILFRED E

  • Director
  • 10% Owner
No longer subject to file 2014-11-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

AUCHINCLOSS THOMAS G - Director

2019-06-13 A 10,000 a 10,000 0.00 direct

BARRETT RONALD W - Director

2019-06-13 A 10,000 a 10,000 0.00 direct

HUTT PETER BARTON - Director

2019-06-13 A 10,000 a 10,000 0.00 direct

VAN HEEK CHRISTI - Director

2019-06-13 A 10,000 a 10,000 0.00 direct

JAEGER WILFRED E - Director

2019-06-13 A 10,000 a 10,000 0.00 direct

HOEILAND JESPER - Director

2019-06-13 A 25,000 a 25,000 0.00 direct

ALDRICH RICHARD - Director

2019-06-13 A 10,000 a 10,000 0.00 direct

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2019-06-10 S 198,256 $10.70 d 1,178,904 169,589.00 direct

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2019-06-10 S 29,450 $10.70 d 169,589 169,589.00 direct

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2019-06-10 S 158,583 $10.70 d 952,859 169,589.00 direct

TUNG ROGER D - Director - Officer CHIEF EXECUTIVE OFFICER

2019-04-23 M 14,601 $3.79 a 631,520 779,056.00 direct

TUNG ROGER D - Director - Officer CHIEF EXECUTIVE OFFICER

2019-04-23 M 14,601 d 14,601 779,056.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments